Stocktoria
Oric Pharmaceuticals, Inc. ORIC
Oric Pharmaceuticals, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 5,126,762 | $55.5M | 5.2% |
| BlackRock Finance, Inc. | 4,830,880 | $34.2M | 4.9% |
| CITADEL ADVISORS LLC | 2,621,299 | $28.4M | 2.66% |
| D. E. Shaw & Co., Inc. | 1,580,216 | $17.1M | 1.6% |
| MILLENNIUM MANAGEMENT LLC | 697,694 | $7.6M | 0.71% |
| TWO SIGMA INVESTMENTS, LP | 603,664 | $6.5M | 0.61% |
| AQR CAPITAL MANAGEMENT LLC | 358,751 | $3.9M | 0.36% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.